TruHearing® Survey Shows U.S. Employees with Hearing Loss Are Underrepresented in DE&I Efforts DRAPER, Utah, Aug. 4, 2022 /PRNewswire/ — While corporate Diversity, Equity, and Inclusion (DE&I) efforts may be on the rise, those with hearing loss are a population that continues to be left…
News
STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition
While a success on paper, the Phase 2 results likely won’t satisfy many investors watching the AI drug developer. Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]
News
STAT+: AI drug developers Recursion, Exscientia to merge
Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia, said they will merge into one company. Click here to view original post Click Here to Publish/Feature Your Company or […]
News
Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche
Plus, news about Seres Therapeutics, Nestlé Health Science, Pfizer, Evotec and Relay Therapeutics: FDA lifts partial hold on Stoke Therapeutics’ Dravet syndrome drug: The antisense oligonucleotide, zorevunersen, is now nearing Phase 3 development for the […]
